explore -WSS

explore

author：hotspot 2025-09-02 22:03:48 - browse：549

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Bacterial infection may be ‘key event’ in endometriosis, study says

focus

WSS

Pfizer highlights cancer drugs it thinks could reignite investor interest

These geoengineering technologies could help combat the climate crisis, scientists say

Bacterial infection may be ‘key event’ in endometriosis, study says

PhRMA sues HHS over Medicare drug price negotiation

These geoengineering technologies could help combat the climate crisis, scientists say

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Change Healthcare cyberattack outage could last weeks

In age of alternative facts, a scholarly course on calling out crap

House looks to weaken Medicare negotiation

What does generative AI mean for health care? We asked experts

Can food be medicine? And other questions about a new push

Drug repurposing or repositioning? The language matters

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Jerome Adams on the need for new antivirals for Covid

House looks to weaken Medicare negotiation

focus

ALS groups 'won't be played again' by the FDA, drug sponsors

Kenai launches with $82 million for Parkinson’s stem cell therapy

Flu vaccine offering decent levels of protection this winter, new data show

Community addresses injustice for Long Island mothers

Option Care buys Amedisys in $3.6 billion home care deal

An inside look at PIPEs, biotech's buzzy new financing tool

focus

focus

hotspot

entertainment